Kazuto Harada

Postdoctoral Fellow

  • 429 Citations
  • 11 h-Index
20122019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Esophageal Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Esophagectomy Medicine & Life Sciences
Stomach Medicine & Life Sciences
Long Interspersed Nucleotide Elements Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Methylation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

  • 429 Citations
  • 11 h-Index
  • 56 Article
  • 10 Review article
  • 3 Editorial
  • 2 Comment/debate

A balancing act: dual immune-checkpoint inhibition for oesophagogastric cancer

Harada, K., Abdelhakeem, A. A. F. & Ajani, J. A., Jan 1 2019, In : Nature Reviews Clinical Oncology. 16, 1, p. 9-10 2 p.

Research output: Contribution to journalComment/debate

CD274 Antigen
Adenocarcinoma
Biomarkers
Morbidity
Mortality

Targeting Angiogenesis in Colorectal Carcinoma

Lopez, A., Harada, K., Vasilakopoulou, M., Shanbhag, N. & Ajani, J. A., Jan 1 2019, In : Drugs. 79, 1, p. 63-74 12 p.

Research output: Contribution to journalReview article

Colorectal Neoplasms
Biosimilar Pharmaceuticals
Therapeutics
Drug Costs
Angiogenesis Inhibitors

The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors

Koga, Y., Iwatsuki, M., Yamashita, K., Kiyozumi, Y., Kurashige, J., Masuda, T., Eto, K., Iwagami, S., Harada, K., Ishimoto, T., Baba, Y., Yoshida, N., Miyanari, N., Takamori, H., Ajani, J. A. & Baba, H., Jan 1 2019, In : Gastric Cancer.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Cell Cycle
Recurrence
Stromal Cells
Notch Receptors

YAP1-mediated CDK6 activation confers radiation resistance in esophageal cancer – Rationale for the combination of YAP1 and CDK4/6 inhibitors in esophageal cancer

Li, F., Xu, Y., Liu, B., Singh, P. K., Zhao, W., Jin, J., Han, G., Scott, A. W., Dong, X., Huo, L., Ma, L., Pizzi, M. P., Wang, Y., Li, Y., Harada, K., Xie, M., Skinner, H., Ding, S., Wang, L., Krishnan, S. & 3 othersJohnson, R. L., Song, S. & Ajani, J. A., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2264-2277 14 p.

Research output: Contribution to journalArticle

Esophageal Neoplasms
Radiation
Neoplastic Stem Cells
Therapeutics
Immunoblotting

Barrett's esophagus after bimodality therapy in patients with esophageal adenocarcinoma

Amlashi, F. G., Wang, X., Davila, R. E., Maru, D. M., Bhutani, M., Lee, J. H., Weston, B., Mizrak Kaya, D., Vassilakopoulou, M., Harada, K., Blum Murphy, M., Rice, D. C., Hofstetter, W. L., Davila, M., Nguyen, Q-N. & Ajani, J. A., Jul 1 2018, In : Oncology (Switzerland). 95, 2, p. 81-90 10 p.

Research output: Contribution to journalArticle

Barrett Esophagus
Adenocarcinoma
Recurrence
Therapeutics
Survival